Pattern play: Abiomed

Price is holding near a new 52-week high after an upside breakout from a bull flag.

New Highs 4

Abiomed (ABMD), a developer of medical devices for cardiovascular conditions, is currently holding around a new 52-week high after breaking out to the upside of an intermediate-term bull flag in mid-December. The RSI is currently in overbought territory at 76. The simple moving averages (SMAs) just turned bullish, as the 20-day SMA just crossed to the upside of the 50-day SMA and the 50-day SMA is above the 200-day SMA. The overbought reading on the RSI could be hinting at a price consolidation. If price can manage to stay above 293.00, then its next targets would be 364.00 and 391.00. On the other hand, if price slips below 293.00, it would be a bearish signal that could send price back to 254.00. If price cannot manage to rebound off of 254.00 then it could be the beginning of a new downtrend.         

Source: GAIN Capital, TradingView

More from Technical Analysis

Disclaimer: The information on this web site is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement. The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient. Any references to historical price movements or levels is informational based on our analysis and we do not represent or warranty that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, author does not guarantee its accuracy or completeness, nor does author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.

Futures, Options on Futures, Foreign Exchange and other leveraged products involves significant risk of loss and is not suitable for all investors. Losses can exceed your deposits. Increasing leverage increases risk. Spot Gold and Silver contracts are not subject to regulation under the U.S. Commodity Exchange Act. Contracts for Difference (CFDs) are not available for US residents. Before deciding to trade forex and commodity futures, you should carefully consider your financial objectives, level of experience and risk appetite. Any opinions, news, research, analyses, prices or other information contained herein is intended as general information about the subject matter covered and is provided with the understanding that we do not provide any investment, legal, or tax advice. You should consult with appropriate counsel or other advisors on all investment, legal, or tax matters. References to or GAIN Capital refer to GAIN Capital Holdings Inc. and its subsidiaries. Please read Characteristics and Risks of Standardized Options.

Open an Account